[Current approach to the management of patients with hemato-oncologic diseases].
作者信息
Goudsmit R, van der Lelie J, Thomas L L
出版信息
Ned Tijdschr Geneeskd. 1987 Nov 14;131(46):2057-9.
PMID:3479701
Abstract
摘要
相似文献
1
[Current approach to the management of patients with hemato-oncologic diseases].[血液肿瘤疾病患者的当前管理方法]
Ned Tijdschr Geneeskd. 1987 Nov 14;131(46):2057-9.
2
[Interferon therapy of hairy cell leukemia and chronic myeloid leukemia].
Ther Umsch. 1988 Feb;45(2):124-30.
3
[Management of hairy cell leukemia with human leukocyte interferons].[用人白细胞干扰素治疗毛细胞白血病]
Duodecim. 1987;103(16):977-80.
4
[Results of a multicenter study of the efficacy of recombinant alpha-2c interferon in hairy cell leukemia].[重组α-2c干扰素治疗毛细胞白血病多中心疗效研究结果]
Ned Tijdschr Geneeskd. 1987 Nov 14;131(46):2081-5.
5
[Interferon-alpha in the treatment of hematologic neoplasms].[α干扰素在血液系统肿瘤治疗中的应用]
Wien Med Wochenschr. 1986 Apr 30;136(7-8):172-81.
6
7
Distinctive acral erythema occurring during therapy for severe myelogenous leukemia.在严重骨髓性白血病治疗期间出现的特异性肢端红斑。
Arch Dermatol. 1985 Jan;121(1):102-4.
8
Human lymphoblastoid alpha-interferon for hairy cell leukemia. An update of the Italian Cooperative Group.
Bone Marrow Transplant. 1989 Jan;4 Suppl 1:179-81.
9
Interferon-alpha: current status and future promise.α干扰素：现状与未来前景
J Biol Response Mod. 1984 Dec;3(6):580-98.
10
Quantitative analysis of bone marrow changes during the treatment of hairy cell leukemia with interferon alpha.
Cancer Treat Rev. 1985 Dec;12 Suppl B:17-22.
Zotero 插件